How to optimize the design and implementation of risk prediction tools: focus group with patients with IgA nephropathy

Abstract Background IgA nephropathy (IgAN) is a common type of chronic immune-mediated kidney disease with variable risk of progression to end-stage kidney disease. Risk stratification helps clinicians weight the potential risks and benefits of immunosuppressive therapy for individual patients, and...

Full description

Bibliographic Details
Main Authors: Anna R. Gagliardi, Heather N. Reich, Daniel C. Cattran, Sean J. Barbour
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Medical Informatics and Decision Making
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12911-020-01253-4